Visa Releases First-of-Its-Kind Industry Benchmark for AI Shopping; Almost Half of Test Runs Fail

Visa Releases First-of-Its-Kind Industry Benchmark for AI Shopping; Almost Half of Test Runs Fail

  • First-of-its-kind1 benchmark tests AI in realistic shopping scenarios—and consumers can try the test, too
  • AI should uncover customer needs and make an informed purchase decision; models failed 42.8% of test runs
  • Benchmark creates a roadmap for industry players to deliver better agentic shopping experiences

SAN FRANCISCO–(BUSINESS WIRE)–
Visa (NYSE: V) today launched Visa Agentic Commerce Benchmark, a new benchmark for industry that puts leading AI models through realistic buying challenges—and is letting people take the test, too.

Shopping is a difficult task for AI because consumers often do not clearly know what they want at the outset—for example, they may know they want a TV, but not all the required specifications. Under Visa’s new benchmark, AI models are required to identify the needs of a consumer based on a conversation. If nothing fits the customer’s requirements, the AI should opt not to buy. To prevent lucky guesses, the AI must uncover enough information to justify its decision.

The first round of tests involved 22 different AI models from 12 labs taking on 15 shopping challenges like buying a TV, laptop, or personal care appliance.

The Results

  • Room for improvement: Across testing, selected AI models achieved an overall benchmark pass rate of about half (57.2%). The best performing models passed 82.2% of attempts, the worst 28.9%.
  • The more you know: The five AI models that uncovered the most hidden buying factors using conversation flows with the consumer averaged a 70.2% pass rate. The five that uncovered the least passed less than half (44.4%) of the time.
  • Pricy models win, but do not guarantee success: The five models with the highest average cost per run passed 67.1% of runs, compared with 50.2% for the five least expensive.
  • Consistency is an issue: Every model got three attempts at each shopping scenario. Across all models and scenarios, all three attempts passed just 34.2% of the time.
  • Buyer beware: About 1-in-2 (54%) of failed runs still ended in the AI making a purchase. Either the AI recommended a purchase that did not meet the customer’s identified requirements, or it failed to uncover all the customer’s requirements.

“AI agents have the potential to power the next era of commerce, but trust is key to making it work,” said Rubail Birwadker, Global Head of Growth at Visa. “Visa Agentic Commerce Benchmark is yet another way Visa is working to boost standards across the industry.”

Superintelligence Sweep

In one scenario, the customer asks for help choosing a new TV. They mention their relative has recommended a brand of television, and that they hold a membership with a third-party supplier—but leave other details unsaid.

Through conversation, the AI must uncover the customer’s budget and additional requirements—such as format compatibility, HDR10+® technology support for family videos, and gaming capabilities.

Models that were better at uncovering the customer’s requirements tended to pass more often. But when made to repeat a scenario they had already passed, the same models often failed—showing how difficult it is to deliver a consistent consumer experience.

Eliminating errors and improving consistency is crucial to building trust in agentic commerce, which is still relatively low today. Visa’s Trust Index, released in September 2026, found that while 72% of U.S. consumers had used an AI assistant, only 23% trusted AI to handle payment transactions on their behalf. Visa Intelligent Commerce, Visa’s portfolio of products, programs and partnerships for agentic commerce, is designed to tackle this challenge.

Visa plans to add other shopping scenarios and product categories to Visa Agentic Commerce Benchmark, and will extend testing to checkout, payment, and order placement. Visa has shared the benchmark with leading model providers for feedback.

Visit Visa Payments Frontier to attempt Visa Agentic Commerce Benchmark yourself, watch replays of AI attempts, and dig deeper into the research with the Visa Agentic Commerce Benchmark whitepaper.

FAQs

Is Visa Agentic Commerce Benchmark part of Visa Intelligent Commerce?

Not directly. Visa Intelligent Commerce is a portfolio of products, programs and partnerships that help bring trust to agentic commerce. The benchmark is complementary research designed to benefit the wider industry.

Is Visa saying AI agents aren’t ready for commerce?

No. The results show promising capabilities, with the highest-scoring models each passing 82.2% of attempts. But consistency and reliability remain challenges.

Is Visa Agentic Commerce Benchmark publicly available?

Yes. Anyone can explore the research and interactive experience on Visa Payments Frontier, including consumers, researchers, developers, merchants, clients and AI companies.

Why is Visa benchmarking AI models?

To help make agentic commerce more reliable. The benchmark gives the industry a consistent way to understand where AI shopping works today and what still needs to improve.

About Visa

Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, sellers, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.

____________________

1 Visa Agentic Commerce Benchmark is the first agentic commerce benchmark to require both discovery of every task-defined customer requirement and a correct purchase or no-purchase decision for a run to pass.

 

Media contact

Conor Febos – [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Technology Payments Finance Other Retail Fintech Electronic Commerce Professional Services Retail Artificial Intelligence

MEDIA:

Logo
Logo

Mobix Labs Wins Military & Commercial Jet Engine-System Orders

Mobix Labs Wins Military & Commercial Jet Engine-System Orders

IRVINE, Calif.–(BUSINESS WIRE)–Mobix Labs, Inc. (Nasdaq: MOBX), a U.S.-based provider of mission-critical aerospace and defense electronics, today announced new six-figure production orders from a tier-one global aerospace and defense supplier for advanced engine-system components used across multiple U.S. fighter jet platforms and wide-body commercial aircraft.

The orders expand Mobix Labs’ presence in critical aircraft engine systems, where its custom connectors protect sensitive engine control and monitoring electronics from electromagnetic interference.

The awards build on the Company’s growing defense business, including its recently announced F-16 production order and an approximately 500% increase in orders supporting the F-22 Raptor. Mobix Labs’ aerospace portfolio also supports the F-35 Lightning II and F/A-18 Super Hornet.

“From America’s frontline fighter jets to the wide-body aircraft carrying passengers around the world, our technology protects electronics where reliability is absolutely essential,” said Phil Sansone, Chief Executive Officer of Mobix Labs. “Winning engine-system business orders from tier-one global aerospace suppliers demonstrates the expanding reach of our technology across military and commercial aviation and reinforces our position in some of the world’s most demanding aerospace applications.”

Forward-Looking Statements

This release contains forward-looking statements concerning Mobix Labs’ business opportunities, aerospace market demand, future orders and growth prospects. Such statements are subject to risks and uncertainties, including changes in customer requirements, order cancellations, production schedules, supply-chain constraints, financing needs and other factors described in the Company’s SEC filings. Actual results may differ materially. Mobix Labs undertakes no obligation to update these statements except as required by law.

X: https://x.com/MobixLabs_MOBX
LinkedIn: Mobix Labs
StockTwits: https://stocktwits.com/MobixLabs

Chris Eddy or David Collins, Catalyst IR
[email protected] or 212-924-9800

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Contracts Hardware Technology White House/Federal Government Defense Engineering Homeland Security Air Transport Aerospace Military Public Policy/Government Manufacturing

MEDIA:

APP Investors Have Opportunity to Lead AppLovin Corporation Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) — Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AppLovin Corporation (“AppLovin” or “the Company”) (NASDAQ: APP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of APP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: February 12, 2026 to August 5, 2026

DEADLINE: November 16, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. AppLovin’s generative AI video tool for its AppLovin Ads platform suffered from significant delays. The Company overstated improvements to its AI models. The Company exaggerated the benefits of the “virtuous cycle” it claimed its AI provided to both customers and itself. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about AppLovin, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. 

CONTACT:

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

Schall, Brown & Schwartz LLP



BIDU Investors Have Opportunity to Lead Baidu, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) — Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baidu, Inc. (“Baidu” or “the Company”) (NASDAQ: BIDU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of BIDU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: November 18, 2025 to August 17, 2026

DEADLINE: November 13, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Baidu overstated the ability of its AI business to cover the rapid decline in its legacy marketing business. The Company was likely to suffer a decline in revenue. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Baidu, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses.

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. 

CONTACT:

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

 Schall, Brown & Schwartz LLP



DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) — Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of DOCS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: August 8, 2024 to May 13, 2026

DEADLINE: November 16, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Doximity overstated the positive impact of its Newsfeed product on revenue growth. The Company’s market share suffered based on competitor’s favorable pricing and engagement models. The Company relied on banner ads and newsletters to delivery advertisements, despite its claims to investors. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Doximity, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. 

CONTACT:

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

 Schall, Brown & Schwartz LLP



Algorhythm Appoints New CEO and Engineering Executive to Accelerate Renewable Power Development

Former IBM DP Executive Greg Smith Named CEO; 40-Year Power Generation Veteran Kevin Tangen Appointed EVP of Engineering and Technology

Fort Lauderdale, FL, Nov. 05, 2026 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (the “Company”) (NASDAQ: RIME), a diversified holding company that owns and operates Azure Energy (“Azure”), a strategic advisor to renewable power plant developers, and SemiCab Holdings, an AI-enabled logistics and distribution company, today announced that its Board of Directors has appointed Greg Smith as Chief Executive Officer, effective October 30, 2026. Mr. Smith succeeds Andrew Thompson, who is stepping down for health reasons and transitioning to a key business development role to focus on the Company’s rapidly increasing pipeline of prospective new business opportunities in the southeastern US.

Mr. Smith is a member of the Company’s Board of Directors, with more than 30 years of management and operational leadership experience from IBM, where he held progressively senior management positions overseeing complex, multinational organizations. His experience includes responsibility for annual budgets of approximately $2 billion, business process management, operational efficiency, and the development of high-value client relationships. Mr. Smith’s appointment is intended to provide leadership continuity while strengthening the Company’s focus on operational execution and the accelerated development of its renewable power generation business.

“I am honored to take on the role of Chief Executive Officer at this important stage in Algorhythm’s development,” said Mr. Smith. “Having served on the Board and been invested in Azure Energy for a number of years, I have developed a strong understanding of the Company’s businesses, strategic priorities, and opportunities ahead. My immediate focus will be on strengthening operational execution, while working with our talented team to advance the Company’s growth objectives and create long-term shareholder value.”

The Company also appointed Kevin Tangen to the role of EVP of Engineering and Technology, adding a 40 year industry veteran to the leadership team. Mr. Tangen is the founder of Azure Engineering, a specialty power generation engineering firm with deep expertise in a wide range of power generation solutions, including renewable natural gas and biomass designs. Mr. Tangen has been a leader in the field for over 40 years, and together with his team has been involved in over 50 power plant design and construction projects. These projects collectively deployed over $5 billion in capital investment to generate over 15 GW of power. Azure Engineering has a deep and active relationship with Azure Energy, which Mr. Tangen was also a 50% co-founder prior to its sale to Algorhythm Holdings in September of this year.

“I am excited to take on this new opportunity in direct support of the new Azure Energy and the entire team at Algorhythm,” commented Mr. Tangen. “Azure Energy has three active projects where I have personally been involved in the engineering to date. It is my belief that by taking on this new role, I can help ensure the entire team across the two organizations move in closer coordination as we hit critical milestones and look to take each project to the key next phases of development in the near term. I also believe that with the new focus on business development, we will need to work even closer together as we head into a potentially pivotal 2027.”

As part of the leadership transition, Mr. Thompson will take on a leadership role in new business development at Azure Energy. Mr. Thompson is specifically tasked with executing on opportunities with municipal partners and commercial sponsors for powered land projects suitable for hyperscaler data center and advanced manufacturing end users. The Company expects the leadership transition to support continuity in its ongoing operations and strategic initiatives, including the development and commercialization of Azure Energy’s renewable power generation projects.

About Algorhythm Holdings

Algorhythm Holdings, Inc. is a holding company with two businesses: Azure Holdings and SemiCab Holdings.

Azure Energy provides strategic and technical advisory services for renewable biomass power generation infrastructure. For additional information, please go to: http://www.azure-energy.co.

SemiCab is an AI-enabled logistics software provider. Since 2020, SemiCab has enabled major retailers, brands, and transportation providers to address common supply-chain problems globally. Its AI-enabled, cloud-based Collaborative Transportation Platform achieves the scalability required to predict and optimize millions of loads and hundreds of thousands of trucks. With SemiCab’s AI platform, shippers pay less and carriers make more without having to change a thing. For additional information, please go to: http://www.semicab.com.

Investor Relations Contact

Brendan Hopkins
407-645-5295
[email protected]
www.algoholdings.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statement that is not historical in nature is a forward-looking statement and may be identified by the use of words and phrases such as “expects,” “anticipates,” “believes,” “will,” “will likely result,” “will continue,” “plans to,” “potential,” “promising,” and similar expressions. These statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including the risk factors described from time to time in Algorhythm’s reports to the SEC, including, without limitation, Algorhythm’s Annual Report on Form 10-K for the year ended December 31, 2025. You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this press release. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this press release to conform our statements to actual results or changed expectations, or as a result of new information, future events or otherwise.



Assurant Acquires Protection Point, Expanding Commercial Equipment Capabilities in Canada

Assurant Acquires Protection Point, Expanding Commercial Equipment Capabilities in Canada

Acquisition adds scale, specialized expertise and distribution capabilities to support continued growth in Canada’s commercial equipment protection market

TORONTO–(BUSINESS WIRE)–
Assurant, Inc. (NYSE: AIZ), a global company that redefines the boundaries of protection – safeguarding and servicing connected devices, homes, automobiles, and commercial equipment in partnership with the world’s leading brands, today announced that it has acquired Protection Point Service Plans Inc. (PPSP), a Canadian provider and administrator of protection programs for commercial equipment.

Based in British Columbia, Protection Point specializes in extended service plans and related protection solutions for commercial equipment across industries including agriculture, construction, material handling and forestry.

The acquisition builds on a longstanding relationship, as Protection Point already operates exclusively in support of Assurant’s commercial equipment business in Canada, with Assurant underwriting its protection programs. By bringing Protection Point into Assurant, the company will strengthen its ability to directly manage distribution, dealer relationships and licensed insurance capabilities in Canada, while creating additional opportunities to expand its Commercial Equipment business.

“Protection Point has been an important partner to Assurant for many years, and bringing the business into Assurant is a natural next step in our relationship,” said Paul Cosgrove, President, Assurant Canada. “The business has built strong relationships and deep expertise in Canada’s commercial equipment market, while delivering impressive growth. Combining those capabilities with Assurant’s scale, underwriting expertise and broader protection platform positions us well to accelerate our growth in this market and deliver even greater value to our clients and their customers.”

The acquisition further strengthens Assurant’s Commercial Equipment capabilities in Canada and complements its established commercial equipment business in the United States.

“Our longstanding partnership with Assurant reflects a shared commitment to our dealers and customers,” said Ian Young, former President, Protection Point. “Joining Assurant builds on that foundation, bringing together our team’s commercial equipment expertise and relationships in Canada with Assurant’s capabilities and investment in commercial equipment protection.”

Protection Point provides end-to-end support across the commercial equipment protection lifecycle, including dealer engagement and onboarding, sales and training, customer support, claims intake and administration, enrollment processing, contract administration, and premium and remittance management.

“Commercial equipment represents an opportunity to build on the capabilities Assurant has developed globally, and Canada is a market where we can extend that expertise,” said Federico Bunge, President, International at Assurant. “Protection Point brings specialized market knowledge, established dealer and manufacturer relationships and a proven sales capability. Together, these complementary strengths will enhance how we serve customers and dealers.”

About Assurant

Assurant, Inc. (NYSE: AIZ) redefines the boundaries of protection – safeguarding and servicing connected devices, homes, automobiles, and commercial equipment in partnership with the world’s leading brands. As a Fortune 500 company operating in 21 countries, Assurant leads the way in leveraging insights and technology to transform customer connections that build loyalty and drive value.

Learn more at assurant.ca.

Media Contact:

Neeti Dhawan

Director, International Communications

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Machinery Professional Services Consumer Electronics Other Construction & Property General Automotive Technology Agriculture Automotive Natural Resources Construction & Property Insurance Manufacturing

MEDIA:

Logo
Logo

The Metals Company Announces Third Quarter 2026 Corporate Update Conference Call for Thursday, November 12, 2026 

NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world’s largest estimated undeveloped resource of critical metals essential to energy, defense, manufacturing and infrastructure, today announced that it will host a conference call on Thursday, November 12, 2026, to provide an update on third quarter 2026 financial results and recent corporate developments. 

Third Quarter 2026 Conference Call Details 

Date:  Thursday, November 12, 2026
     
Time:  4:30 p.m. ET 
     
Audio-only Dial-in:  Register Here 
    
Virtual webcast with slides:  Register Here 
   

The virtual webcast will be available for replay in the ‘Investors’ tab of the Company’s website under ‘Investors’ > ‘Media’ > ‘Events and Presentations’, approximately two hours after the event.

About The Metals Company
The Metals Company is a developer of lower-impact critical metals from seafloor polymetallic nodules, on a dual mission: (1) supply metals for energy, defense, manufacturing and infrastructure with net positive impacts compared to conventional production routes and (2) trace, recover and recycle the metals we supply to help create a metal commons that can be used in perpetuity. The Company has conducted more than a decade of research into the environmental and social impacts of offshore nodule collection and onshore processing. More information is available at www.metals.co.

Contacts 
Media | [email protected]  
Investors | [email protected]  



Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry

  • The 6-month target lesion primary patency (TLPP)

    1

    and access circuit primary patency (ACPP)

    2

    for patients in the arteriovenous fistula (AVF) cohort were 92.7% and 76.7%, respectively
  • The real-world patency results observed in the WRAP Global Registry are higher than the patency results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial, validating the already favorable performance of the device

SOUTH JORDAN, Utah, Nov. 05, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced results from the AVF cohort of the WRAPSODY (WRAP) Global registry. Clinical data were presented during the New Innovations, Trials, Techniques & Devices session on Saturday, October 31, 2026, at the Controversies in Dialysis Access (CiDA)* conference held in Washington, DC.

Hemodialysis is a life-sustaining therapy for patients diagnosed with advanced kidney disease. For many patients, the creation and long-term maintenance of an AVF is essential for ongoing access to blood vessels (vascular access). However, impairments in and around the fistula due to progressive narrowing (stenosis) and/or blockage (occlusion) are inevitable for some patients. These obstructions can interfere with a patient’s ability to receive hemodialysis, require repeated interventions, and may result in life-threatening consequences.

The WRAPSODY™ Cell-Impermeable Endoprosthesis (CIE) was developed to restore functionality in vascular access in patients who experience stenosis/occlusion. The device’s favorable performance has been documented in the clinical trial setting.3–6 Real-world data provide insight into how a medical device performs when used in routine clinical practice, outside the controlled setting of a traditional clinical trial. The WRAP Global registry is an international, multicenter, prospective study designed to evaluate the performance of the WRAPSODY CIE in real-world clinical practice through 24 months following device placement. A total of 237 patients were enrolled in the AVF cohort across 31 sites in nine countries. The 6-month TLPP1 was 92.7%, and the 6-month ACPP2 was 76.7%. These findings align with the patency rates observed in the AVF cohort in the WAVE pivotal trial (6-month TLPP: 89.8%; 6-month ACPP: 72.8%).4

“These are the results physicians have been waiting for,” said Panagiotis M. Kitrou, MD, MSc, PhD, EBIR, FCIRSE, Co-Global Principal Investigator of the WRAP Global registry, Associate Professor of Interventional Radiology at Patras University Hospital in Patras, Greece, and a clinical consultant to Merit Medical. “Real-world insight regarding the patency of WRAPSODY provides an important benchmark for this patient population.”

“The promising patency outcomes from the WRAP Global registry are likely to improve physician confidence in the clinical benefits associated with WRAPSODY and help to further optimize patient care,” said Dheeraj K. Rajan, MD, Co-Global Principal Investigator of the WRAP Global registry, Professor and Division Head in the Department of Vascular Interventional Radiology at the University of Toronto in Toronto, Canada, who also serves as a clinical advisor to Merit Medical.

“These results reinforce our commitment to building a comprehensive body of clinical evidence for WRAPSODY, which includes both rigorous clinical trials and real-world practice,” said Martha G. Aronson, Merit’s President and Chief Executive Officer. “Helping physicians maintain vascular access and reduce the burden associated with repeat interventions is central to what we are working to achieve for patients receiving hemodialysis worldwide.”

The WRAPSODY CIE received premarket approval from the U.S. Food and Drug Administration (FDA) in December 2024 and was approved by Health Canada in April 2025. In January 2025, Merit began commercialization of the device in the United States. The device previously received the Conformité Européenne (CE) Mark for commercial use in the European Union and is available in Brazil.

In addition to the WRAP Global registry, real-world clinical outcomes of the WRAPSODY CIE are being evaluated in the WRAP North America registry, which is designed to enroll up to 250 patients in the United States and Canada. For additional information on Merit’s WRAP North America registry, please visit: https://clinicaltrials.gov/study/NCT06807099.

Merit believes that the collective data from the WAVE trial, the WRAP North America registry, and the WRAP Global registry will generate evidence on the largest cohort of patients for a single indication in dialysis access to date.

For more information on the WRAPSODY CIE within the United States, please visit: https://www.merit.com/product/wrapsody-cie/. For information on the device outside of the United States, please visit: https://www.merit.com/product/merit-wrapsody/.

Cautionary statement regarding forward-looking statements

Any forward-looking statements set forth in this release are subject to risks and uncertainties such as those described in Merit’s filings with the U. S. Securities and Exchange Commission (“SEC”). For discussion of the risks and uncertainties which may affect Merit’s business, operations and financial condition, see Part I, Item 1A, “Risk Factors” in Merit’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC, which Merit updated in Part II, Item 1A, “Risk Factors” in Merit’s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026, June 30, 2026 and September 30, 2026, which Merit filed with the SEC. Actual results will likely differ, and may differ materially, from anticipated results.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling approximately 900 individuals. Merit employs approximately 7,500 people worldwide.

*ABOUT CiDA

Controversies in Dialysis Access (CiDA) is a leading multidisciplinary educational forum dedicated to advancing the care of patients requiring dialysis access. Established in 2003, CiDA brings together vascular surgeons, interventional radiologists, nephrologists, and other healthcare professionals to examine current challenges, emerging technologies, clinical research, and evolving approaches to dialysis access management. Through expert presentations, interactive debates, case discussions, and hands-on education, CiDA promotes collaboration and the exchange of knowledge to improve patient care.

For more information, visit www.dialysiscontroversies.org.

TRADEMARKS

Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.

CONTACTS

PR/Media Inquiries
Sarah Comstock
Merit Medical
+1-801-432-2864 | [email protected]

INVESTOR INQUIRIES
Mike Piccinino, CFA, IRC
Westwicke – ICR
+1-443-213-0509 | [email protected]

  1. TLPP (primary effectiveness endpoint) was defined as the proportion of patients who did not require an intervention due to clinically driven target lesion revascularization or target lesion thrombosis.
  2. ACPP (a secondary effectiveness endpoint) was defined as the proportion of patients without loss of vascular access anywhere within the circuit from the time of their initial treatment to the need for reintervention or abandonment of vascular access.
  3. Gilbert et al. 2021. “First Clinical Results of the Merit WRAPSODY™ Cell-Impermeable Endoprosthesis for Treatment of Access Circuit Stenosis in Haemodialysis Patients.” Cardiovasc Interv Radiol 44, no. 12 (Dec): 1903–13. doi: 10.1007/s00270-021-02953-8.
  4. Razavi et al. 2025. “Six-Month Safety and Efficacy Outcomes from the Randomized-Controlled Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial.” Kidney Int 107, no. 4 (Apr): 740–50. doi: 10.1016/j.kint.2025.01.006.
  5. Razavi et al. 2026. “One-Year Clinical Outcomes from the Randomized-Controlled Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial.” J Vasc Interv Radiol 37, no. 6 (Jun): 108593. Online ahead of print. doi: 10.1016/j.jvir.2026.108593.
  6. Razavi et al. 2026. “Safety and Effectiveness of the Wrapsody Cell-Impermeable Endoprosthesis to Treat Dysfunctional Arteriovenous Grafts: Results from the Nonrandomized Arm of the WAVE Trial.” J Vasc Interv Radiol 37, no. 6 (Jun): 108594. Online ahead of print. doi: 10.1016/j.jvir.2026.108594.



AST SpaceMobile Awarded U.S. Space Force Contract Through STR to Advance Space-Based Sensing Capabilities

AST SpaceMobile Awarded U.S. Space Force Contract Through STR to Advance Space-Based Sensing Capabilities

Award supports use of commercial space technology for government applications beyond communications

MIDLAND, Texas–(BUSINESS WIRE)–
AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced it will support STR, the prime contractor, under a U.S. Space Force (USSF) contract.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104508354/en/

This effort supports an additional phase of technology development to advance sensing capabilities using AST SpaceMobile’s commercially developed space-based technologies. The work is being performed under a government program intended to evaluate and leverage commercial innovation for national security applications.

AST SpaceMobile has worked with STR on related efforts drawing on prior on-orbit experience. This work builds on that technical foundation and reflects the potential of commercially developed dual-use technology, to support evolving government needs.

“The technology and platform capabilities of our BlueBird spacecraft combine proprietary design, the largest phased array ever deployed in low Earth orbit, and a multi-frequency architecture that can support millions of users and dozens of use cases across airborne, maritime, and ground domains,” said Chris Ivory, Chief Executive Officer of AST SpaceMobile Defense. “Our experience deploying phased arrays in low Earth orbit, combined with deep engineering expertise and technology supported by more than 3,900 patent and patent-pending claims, demonstrates the potential of our platform to support commercial applications and the technology-development activities being evaluated under this contract.”

AST SpaceMobile’s next-generation BlueBird platform combines advanced connectivity and onboard processing with a scalable architecture. Designed to support an expanding range of commercial and government applications, including communications and other potential mission needs, the platform can evolve as new capabilities and requirements emerge.

The BlueBird spacecraft are assembled, integrated, and tested at AST SpaceMobile’s facilities in Midland Texas, reflecting the company’s commitment to U.S.-based innovation and manufacturing. AST SpaceMobile operates over 500,000 square feet of manufacturing and operations facilities worldwide and employs a workforce of more than 2,250 people.

About AST SpaceMobile

AST SpaceMobile is building the first and only global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on our extensive IP and patent portfolio and designed for both commercial and government applications. Our engineers and space scientists are on a mission to enable 4G and 5G space-based cellular broadband to every device, everywhere, for today’s nearly 6 billion mobile subscribers globally. The BlueBird spacecraft – the largest phased arrays ever deployed in low Earth orbit, at approximately 2,400 square feet (223 square meters) – are assembled, integrated, and tested at AST SpaceMobile’s facilities in Midland Texas, reflecting the company’s commitment to U.S.-based innovation and manufacturing. AST SpaceMobile now operates over 500,000 square feet of manufacturing and operations facilities worldwide, supported by a 2,250+ workforce, and a technology platform backed by over 3,900 patents and patent-pending claims.

For more information, follow AST SpaceMobile on YouTube, X (Formerly Twitter), LinkedIn and Facebook. Watch this video for an overview of the SpaceMobile mission.

Forward-Looking Statements

This communication contains “forward-looking statements” that are not historical facts, and involve risks and uncertainties that could cause actual results of AST SpaceMobile to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “would,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside AST SpaceMobile’s control and are difficult to predict.

Factors that could cause such differences include, but are not limited to: (i) expectations regarding AST SpaceMobile’s strategies and future financial performance, including AST’s future business plans or objectives, expected functionality of the SpaceMobile Service, anticipated timing of the launch of the Block 2 BlueBird satellites, anticipated demand and acceptance of mobile satellite services, prospective performance and commercial opportunities and competitors, the timing of obtaining regulatory approvals, ability to finance its research and development activities, commercial partnership acquisition and retention, products and services, pricing, marketing plans, operating expenses, market trends, revenues, liquidity, cash flows and uses of cash, capital expenditures, and AST SpaceMobile’s ability to invest in growth initiatives; (ii) the negotiation of definitive agreements with mobile network operators relating to the SpaceMobile Service that would supersede preliminary agreements and memoranda of understanding and the ability to enter into commercial agreements with other parties or government entities; (iii) the ability of AST SpaceMobile to grow and manage growth profitably and retain its key employees and AST SpaceMobile’s responses to actions of its competitors and its ability to effectively compete; (iv) changes in applicable laws or regulations; (v) the possibility that AST SpaceMobile may be adversely affected by other economic, business, and/or competitive factors; (vi) the outcome of any legal proceedings that may be instituted against AST SpaceMobile; and (vii) other risks and uncertainties indicated in the Company’s filings with the Securities and Exchange Commission (SEC), including those in the Risk Factors section of AST SpaceMobile’s Form 10-K filed with the SEC on March 2, 2026, its Form 10-Q for the fiscal quarter ended March 31, 2026 filed with the SEC on May 11, 2026 and the future reports that it may file from time to time with the SEC.

AST SpaceMobile cautions that the foregoing list of factors is not exclusive. AST SpaceMobile cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors in AST SpaceMobile’s Form 10-K filed with the SEC on March 2, 2026, its Form 10-Q for the fiscal quarter ended March 31, 2026 filed with the SEC on May 11, 2026 and the future reports that it may file from time to time with the SEC. AST SpaceMobile’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, AST SpaceMobile disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Investor Contact:

Scott Wisniewski

[email protected]

Media Contact:

Allison Worldwide

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Aerospace Technology Manufacturing Telecommunications Military Government Technology Defense Contracts Internet Mobile/Wireless 5G

MEDIA:

Photo
Photo
Logo
Logo